Your browser doesn't support javascript.
loading
An iron-dependent metabolic vulnerability underlies VPS34-dependence in RKO cancer cells.
Kobylarz, Marek J; Goodwin, Jonathan M; Kang, Zhao B; Annand, John W; Hevi, Sarah; O'Mahony, Ellen; McAllister, Gregory; Reece-Hoyes, John; Wang, Qiong; Alford, John; Russ, Carsten; Lindeman, Alicia; Beibel, Martin; Roma, Guglielmo; Carbone, Walter; Knehr, Judith; Loureiro, Joseph; Antczak, Christophe; Wiederschain, Dmitri; Murphy, Leon O; Menon, Suchithra; Nyfeler, Beat.
Afiliación
  • Kobylarz MJ; Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America.
  • Goodwin JM; Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America.
  • Kang ZB; Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America.
  • Annand JW; Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America.
  • Hevi S; Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America.
  • O'Mahony E; Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America.
  • McAllister G; Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America.
  • Reece-Hoyes J; Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America.
  • Wang Q; Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America.
  • Alford J; Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America.
  • Russ C; Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America.
  • Lindeman A; Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America.
  • Beibel M; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Roma G; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Carbone W; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Knehr J; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Loureiro J; Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America.
  • Antczak C; Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America.
  • Wiederschain D; Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America.
  • Murphy LO; Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America.
  • Menon S; Novartis Institutes for Biomedical Research, Cambridge, MA, United States of America.
  • Nyfeler B; Novartis Institutes for Biomedical Research, Basel, Switzerland.
PLoS One ; 15(8): e0235551, 2020.
Article en En | MEDLINE | ID: mdl-32833964
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fosfatidilinositol 3-Quinasas Clase III / Hierro / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fosfatidilinositol 3-Quinasas Clase III / Hierro / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos